GSK plc
GSKView Detailed Chart
36.530USD
-2.485-6.37%
Close 04/04, 16:00（ET）Quotes delayed by 15 min
75.71BMarket Cap
23.22P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-6.37%
5 Days
-5.68%
1 Month
-5.87%
6 Months
-5.89%
Year to Date
+8.01%
1 Year
-11.31%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
8
analysts
HOLD
Current Rating
39.708
Target Price
8.70%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
150
Total
5
Median
7
Average
Company name
Ratings
Analysts
GSK plc
GSK
8
Biogen Inc
BIIB
37
Alnylam Pharmaceuticals Inc
ALNY
33
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
BioMarin Pharmaceutical Inc
BMRN
29
1
2
3
...
30
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Sell
Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.649
Neutral
RSI(14)
39.931
Neutral
STOCH(KDJ)(9,3,3)
31.260
Neutral
ATR(14)
0.886
High Vlolatility
CCI(14)
-188.932
Sell
Williams %R
93.932
Oversold
TRIX(12,20)
0.106
Sell
StochRSI(14)
0.000
Sell
Moving Average
Indicators
Value
Direction
MA5
37.958
Sell
MA10
38.252
Sell
MA20
38.810
Sell
MA50
37.102
Sell
MA100
35.696
Buy
MA200
37.966
Sell
News
More news coming soon, stay tuned...
Company
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Its specialty medicines prevent and treat diseases, from human immunodeficiency virus (HIV) to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases. Its portfolio also includes the lead molecule IDRX-42, highly selective tyrosine kinase inhibitor (TKI) that is designed to improve patients with gastrointestinal stromal tumors (GIST).
Company codeGSK
CompanyGSK plc
CEOMs. Deborah Waterhouse
Websitehttps://www.gsk.com/
